CATALAYER NEWS
Intellia presents Phase 3 results for HAE gene therapy lonvo-z
Source: Investing.com · 2026-06-13
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
Memory chip shortage: How crazy could it get?
2026-06-13
Agios presents detailed mitapivat trial results for sickle cell
2026-06-13
Who are the winners & losers in the quantum future
2026-06-13
Rhythm Pharmaceuticals reports phase 2 PWS trial results
2026-06-13
Why an Iran deal might not be dovish for the Fed
2026-06-13
RELATED ON CATALAYER
Mentioned Tickers
$INTC · IntelRelated Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets